Global Preclinical CRO Market Growth (Status and Outlook) 2025-2031

Global Preclinical CRO Market Growth (Status and Outlook) 2025-2031

The global Preclinical CRO market size is predicted to grow from US$ 17400 million in 2025 to US$ 28340 million in 2031; it is expected to grow at a CAGR of 8.5% from 2025 to 2031.

A preclinical CRO (contract research organizations) helps new medical product developers (including devices, drugs, biologics and more) prove those products are safe and effective in live models the FDA deems approximate as closely as possible the human anatomy prior to those devices enter clinical trials (or receiving other approvals like 510Ks) or use for human care.

The Global key players of Preclinical CRO include Wuxi AppTec, Charles River, Labcorp, etc. The top three players hold a share about 43%. US & Canada is the largest market, and has a share about 45%. In terms of product type, Bioanalysis and DMPK Studies is the largest segment, which occupied for a share of about 47%. For application, Pharmaceutical Companies is the largest segment, which has a share about 79%.

LPI (LP Information)' newest research report, the “Preclinical CRO Industry Forecast” looks at past sales and reviews total world Preclinical CRO sales in 2024, providing a comprehensive analysis by region and market sector of projected Preclinical CRO sales for 2025 through 2031. With Preclinical CRO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Preclinical CRO industry.

This Insight Report provides a comprehensive analysis of the global Preclinical CRO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Preclinical CRO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Preclinical CRO market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Preclinical CRO and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Preclinical CRO.

This report presents a comprehensive overview, market shares, and growth opportunities of Preclinical CRO market by product type, application, key players and key regions and countries.

Segmentation by Type:
Bioanalysis and DMPK Studies
Toxicology Testing
Safety Pharmacology
Others

Segmentation by Application:
Pharmaceutical Companies
Medical Device Companies
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Wuxi AppTec
Charles River
Labcorp
Eurofins Scientific
PPD, Inc.
ICON Plc.
Pharmaron
Inotiv
ChemPartner
JOINN Lab
EVOTEC
Medicilon
Crown Bioscience
Champion Oncology

Please note: The report will take approximately 2 business days to prepare and deliver.